Compounded Tirzepatide with B12

Obesity is a chronic health condition in the United States affecting millions of Americans yearly. Being obese can put you at risk for Type 2 Diabetes, Hypertension, and Cardiovascular issues. Compounded Tirzepatide weight loss medication is an injectable medication that is administered once weekly. It can be used by adults with a body mass index (BMI) greater than or equal to 30 mg/kg² alone or 27 mg/kg² with at least one weight-related condition including high blood pressure, high cholesterol, polycystic ovarian disease, and Type 2 diabetes).

Compounded Tirzepatide weight loss medication is a weekly injection that has been shown in clinical trials to be useful for weight loss, although currently it is not an FDA-approved weight loss medication. Compounded Tirzepatide weight loss medication works by activating the GIP and GLP-1 receptors. Compounded Tirzepatide weight loss medication is only indicated for adults and should be used along with diet and exercise.

Compounded Tirzepatide weight loss medication has been proven to improve high blood sugar levels and reduce chronic health conditions such as polycystic ovarian syndrome, hypertension, and hypercholesterolemia.

Compounded Tirzepatide weight loss medication does not contain a stimulant. The medication will help you stay full longer and feel full faster resulting in smaller meals and stable blood sugars. Clinical studies show a 15-20% reduction in body weight.

Compounded Tirzepatide weight loss medication should be used in combination with lifestyle changes, including a healthy diet and exercise to maximize the benefits of the medication. Belle Wellness sources Compounded Tirzepatide weight loss medication from a compounding pharmacy in the United States that is heavily regulated by the FDA ensuring a high safety profile for our patients.

Who should not take Compounded Tirzepatide?

Individuals with a history of:

· MEN2 is also known as multiple endocrine neoplasia type 2 (tumors in your glands).

· A personal or family history of medullary thyroid carcinoma (a type of thyroid cancer).

· A stomach or intestinal disorder.

· History of pancreatitis.

· Kidney disease

· Eye problems caused by diabetes (Retinopathy).

· Pregnant, plan to get pregnant within a couple of months, or are breastfeeding.

In animal studies, Compounded Tirzepatide weight loss medication caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people.

Men and Women should stop using Compounded Tirzepatide weight loss medication at least 2 months before you plan to get pregnant.

Compounded Tirzepatide weight loss medication should not be used in people with Type 1 diabetes.